Hedgehog-GLI signalling promotes chemoresistance through the regulation of ABC transporters in colorectal cancer cells
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hedgehog-GLI signalling promotes chemoresistance through the regulation of ABC transporters in colorectal cancer cells
Authors
Keywords
-
Journal
Scientific Reports
Volume 10, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-08-19
DOI
10.1038/s41598-020-70871-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Oxaliplatin resistance is enhanced by saracatinib via upregulation Wnt-ABCG1 signaling in hepatocellular carcinoma
- (2020) Xia Liao et al. BMC CANCER
- Inhibition of MALAT1 reduces tumor growth and metastasis and promotes drug sensitivity in colorectal cancer
- (2019) Dongxin Tang et al. CELLULAR SIGNALLING
- ABCG1 and Pgp identify drug resistant, self-renewing osteosarcoma cells
- (2019) Elizabeth Ann Roundhill et al. CANCER LETTERS
- Non-canonical Hedgehog Signaling Pathway in Cancer: Activation of GLI Transcription Factors Beyond Smoothened
- (2019) Silvia Pietrobono et al. Frontiers in Genetics
- Targeting chemoresistant colorectal cancer via systemic administration of a BMP7 variant
- (2019) Veronica Veschi et al. ONCOGENE
- Hedgehog Signals Mediate Anti-Cancer Drug Resistance in Three-Dimensional Primary Colorectal Cancer Organoid Culture
- (2018) Tatsuya Usui et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Oxaliplatin resistance in colorectal cancer cells is mediated via activation of ABCG2 to alleviate ER stress induced apoptosis
- (2018) Hsi-Hsien Hsu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Foxm1 controls a pro-stemness microRNA network in neural stem cells
- (2018) Zein Mersini Besharat et al. Scientific Reports
- Clinical utility of ABCB1 genotyping for preventing toxicity in treatment with irinotecan
- (2018) Sara Salvador-Martín et al. PHARMACOLOGICAL RESEARCH
- Drug resistance and new therapies in colorectal cancer
- (2018) Kevin Van der Jeught et al. WORLD JOURNAL OF GASTROENTEROLOGY
- p53 Represses the Mevalonate Pathway to Mediate Tumor Suppression
- (2018) Sung-Hwan Moon et al. CELL
- Noncanonical GLI1 signaling promotes stemness features and in vivo growth in lung adenocarcinoma
- (2017) A Po et al. ONCOGENE
- The histone methyltransferase EZH2 as a druggable target in SHH medulloblastoma cancer stem cells
- (2017) Evelina Miele et al. Oncotarget
- The role of GLI1 for 5-Fu resistance in colorectal cancer
- (2017) Lining Zhang et al. Cell and Bioscience
- Wnt-β-catenin signaling regulates ABCC3 (MRP3) transporter expression in colorectal cancer
- (2016) Minoru Kobayashi et al. CANCER SCIENCE
- Genetic variants inABCG1are associated with survival of nonsmall-cell lung cancer patients
- (2016) Yanru Wang et al. INTERNATIONAL JOURNAL OF CANCER
- Mechanisms of drug resistance in colon cancer and its therapeutic strategies
- (2016) Tao Hu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- HEDGEHOG/GLI-E2F1 axis modulates iASPP expression and function and regulates melanoma cell growth
- (2015) S Pandolfi et al. CELL DEATH AND DIFFERENTIATION
- The role of ABC transporters in ovarian cancer progression and chemoresistance
- (2015) M.P. Ween et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Proteomic analysis of human sonic hedgehog (SHH) medulloblastoma stem-like cells
- (2015) Maurizio Ronci et al. Molecular BioSystems
- ABCC5 and ABCG1 polymorphisms predict irinotecan-induced severe toxicity in metastatic colorectal cancer patients
- (2015) Sylvia Chen et al. Pharmacogenetics and Genomics
- Polymorphisms in ATP-binding cassette transporter genes and interaction with diet and life style factors in relation to colorectal cancer in a Danish prospective case-cohort study
- (2015) Tine Iskov Kopp et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Mode and specificity of binding of the small molecule GANT61 to GLI determines inhibition of GLI-DNA binding
- (2015) Akwasi Agyeman et al. Oncotarget
- Analysis of TP53 Mutation Status in Human Cancer Cell Lines: A Reassessment
- (2014) Bernard Leroy et al. HUMAN MUTATION
- Arsenic trioxide inhibits tumor cell growth in malignant rhabdoid tumorsin vitroandin vivoby targeting overexpressed Gli1
- (2014) Kornelius Kerl et al. INTERNATIONAL JOURNAL OF CANCER
- Colorectal cancer
- (2013) Hermann Brenner et al. LANCET
- Hedgehog signaling regulates drug sensitivity by targeting ABC transporters ABCB1 and ABCG2 in epithelial ovarian cancer
- (2013) Yi Chen et al. MOLECULAR CARCINOGENESIS
- Unraveling the therapeutic potential of the Hedgehog pathway in cancer
- (2013) Dereck Amakye et al. NATURE MEDICINE
- A Randomized Phase II Trial of Vismodegib versus Placebo with FOLFOX or FOLFIRI and Bevacizumab in Patients with Previously Untreated Metastatic Colorectal Cancer
- (2012) J. Berlin et al. CLINICAL CANCER RESEARCH
- CD133+ colon cancer cells are more interactive with the tumor microenvironment than CD133− cells
- (2011) Celia Chao et al. LABORATORY INVESTIGATION
- ABCG2 is a direct transcriptional target of hedgehog signaling and involved in stroma-induced drug tolerance in diffuse large B-cell lymphoma
- (2011) R R Singh et al. ONCOGENE
- ATP binding cassette transporter G1 (ABCG1) is an intracellular sterol transporter
- (2011) E. J. Tarling et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reversal of gene expression changes in the colorectal normal-adenoma pathway by NS398 selective COX2 inhibitor
- (2010) O Galamb et al. BRITISH JOURNAL OF CANCER
- A Phase I Study of 5-Fluorouracil/Leucovorin and Arsenic Trioxide for Patients with Refractory/Relapsed Colorectal Carcinoma
- (2010) B. Ardalan et al. CLINICAL CANCER RESEARCH
- A GLI1-p53 inhibitory loop controls neural stem cell and tumour cell numbers
- (2009) Barbara Stecca et al. EMBO JOURNAL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started